Literature DB >> 19706898

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia.

Mercè Herrero1, Giannos Orfanos, Daniel Argaw, Abate Mulugeta, Pilar Aparicio, Fernando Parreño, Oscar Bernal, Daniel Rubens, Jaime Pedraza, Maria Angeles Lima, Laurence Flevaud, Pedro Pablo Palma, Seife Bashaye, Jorge Alvar, Caryn Bern.   

Abstract

In May 2005, visceral leishmaniasis (VL) was recognized for the first time in Libo Kemken, Ethiopia, a highland region where only few cases had been reported before. We analyzed records of VL patients treated from May 25, 2005 to December 13, 2007 by the only VL treatment center in the area, maintained by Médecins Sans Frontières-Ethiopia, Operational Center Barcelona-Athens. The median age was 18 years; 77.6% were male. The overall case fatality rate was 4%, but adults 45 years or older were five times as likely to die as 5-29 year olds. Other factors associated with increased mortality included HIV infection, edema, severe malnutrition, pneumonia, tuberculosis, and vomiting. The VL epidemic expanded rapidly over a several-year period, culminating in an epidemic peak in the last third of 2005, spread over two districts, and transformed into a sustained endemic situation by 2007.

Entities:  

Mesh:

Year:  2009        PMID: 19706898

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  Low prevalence of Leishmania infection in post-epidemic areas of Libo Kemkem, Ethiopia.

Authors:  Luis Sordo; Endalamaw Gadisa; Estefanía Custodio; Israel Cruz; Fernando Simón; Zelalem Abraham; Javier Moreno; Abraham Aseffa; Hailu Tsegaye; Javier Nieto; Carmen Chicharro; Carmen Cañavate
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B.

Authors:  François Chappuis; Emilie Alirol; Dagemlidet T Worku; Yolanda Mueller; Koert Ritmeijer
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.

Authors:  Carmen Cañavate; Merce Herrero; Javier Nieto; Israel Cruz; Carmen Chicharro; Pilar Aparicio; Abate Mulugeta; Daniel Argaw; Anna J Blackstock; Jorge Alvar; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

4.  Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.

Authors:  Endalamaw Gadisa; Estefanía Custodio; Carmen Cañavate; Luis Sordo; Zelalem Abebe; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Lawrence Yamuah; Howard Engers; Javier Moreno; Israel Cruz
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

5.  Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia.

Authors:  Michael O Harhay; Piero L Olliaro; Michel Vaillant; François Chappuis; María Angeles Lima; Koert Ritmeijer; Carlos Henrique Costa; Dorcas Lamounier Costa; Suman Rijal; Shyam Sundar; Manica Balasegaram
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

6.  Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.

Authors:  Francesco Di Masi; Tamara Ursini; Maria Donata Iannece; Leonardo Chianura; Francesco Baldasso; Giuseppe Foti; Pietro Di Gregorio; Angelo Casabianca; Nunzio Storaci; Luciano Nigro; Claudia Colomba; Maria Grazia Marazzi; Giovanni Todaro; Giacinta Tordini; Giacomo Zanelli; Giovanni Cenderello; Nicola Acone; Ennio Polilli; Simona Migliore; Paolo Almi; Eligio Pizzigallo; Evangelista Sagnelli; Francesco Mazzotta; Rosario Russo; Lamberto Manzoli; Giustino Parruti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

7.  Visceral Leishmaniasis in Benishangul-Gumuz Regional State, Western Ethiopia: Reemerging or Emerging?

Authors:  Adugna Abera; Geremew Tasew; Teshome Tsegaw; Asfaw Kejella; Abate Mulugeta; Dagimlidet Worku; Abraham Aseffa; Endalamaw Gadisa
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

Review 8.  Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review.

Authors:  Grace Grifferty; Hugh Shirley; Jamie McGloin; Jorja Kahn; Adrienne Orriols; Richard Wamai
Journal:  Res Rep Trop Med       Date:  2021-06-23

9.  Knowledge, attitude and practices related to visceral leishmaniasis among residents in Addis Zemen town, South Gondar, Northwest Ethiopia.

Authors:  Agersew Alemu; Abebe Alemu; Nuraini Esmael; Yared Dessie; Kedir Hamdu; Biniam Mathewos; Wubet Birhan
Journal:  BMC Public Health       Date:  2013-04-24       Impact factor: 3.295

Review 10.  The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination.

Authors:  Kebede Deribe; Kadu Meribo; Teshome Gebre; Asrat Hailu; Ahmed Ali; Abraham Aseffa; Gail Davey
Journal:  Parasit Vectors       Date:  2012-10-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.